arrow
A

Asfar S. Azmi

wayne state university
H指数:65
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

抑制CDK9增强了由联合维奈克拉和阿扎胞苷诱导的急性髓系白血病细胞死亡

2025-09-160
OAAI
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

ADT-1004: 在胰腺导管腺癌的临床前模型中具有强大抗肿瘤活性的一流口服pan-ras抑制剂

2025-03-130
OA
Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia

Ziftomenib与Selinexor的联合使用对NPM1突变急性髓系白血病有效

BLOOD
IF23.1
2024-11-051
PRE
Next generation nuclear export blocker KPT8602 synergizes with KRASG12D inhibitor MRTX1133 resulting in improved antitumor effects against pancreatic ductal adenocarcinoma
2024-03-220
PRE
KRASG12D inhibitor MRTX1133 synergizes with the next generation nuclear transport protein inhibitor eltanexor resulting in enhanced antitumor activity against pancreatic ductal adenocarcinoma

KRASG12D抑制剂MRTX1133与下一代核转运蛋白抑制剂eltanexor协同作用,增强对胰腺导管腺癌的抗肿瘤活性

2024-01-160
PRE
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model

XPO1抑制剂和吉西他滨-nab-紫杉醇联合应用在KPC胰腺癌小鼠模型中的分子分析

2023-12-225
OA